Fascin is involved in tumor necrosis factor-α-dependent production of MMP9 in cholangiocarcinoma

Laboratory Investigation

Volumn 89, Issue 11, 2009, Pages 1261-1274

  Onodera, Manabu ^a,b   Zen, Yoh ^c   Harada, Kenichi ^a   Sato, Yasunori ^a   Ikeda, Hiroko ^a   Itatsu, Keita ^d   Sato, Hiroshi ^e   Ohta, Tetsuo ^a   Asaka, Masahiro ^b   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cholangiocarcinoma; Fascin; Invasion; MMP9; Prognosis; TNF a

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; FASCIN; GELATINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR GROWTH; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT; CARRIER PROTEINS; CELL COUNT; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 9; MICROFILAMENT PROTEINS; MIDDLE AGED; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350630548     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.89     Document Type: Article

References (43)

1. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004;16:590-596.
2. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 2005;37:1787-1804.
3. Kureishy N, Sapountzi V, Prag S, et al Fascins, and their roles in cell structure and function. Bioessays 2002;24:350-361.
4. Kane RE. Preparation and purification of polymerized actin from sea urchin egg extracts. J Cell Biol 1975;66:305-315.
5. Cant K, Knowles BA, Mooseker MS, et al Drosophila singed, a fascin homolog, is required for actin bundle formation during oogenesis and bristle extension. J Cell Biol 1994;125:369-380.
6. Sialos G, Yamashiro S, Baughman RW, et al Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J Virol 1994;68:7320-7328.
7. De Arcangelis A, Georges-Labouesse E, Adams JC. Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis. Gene Expr Patterns 2004;4:637-643.
8. Maitra A, Iacobuzio-Donahue C, Rahman A, et al Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol 2002;118:52-59.
9. Maitra A, Adsay NV, Argani P, et al Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 2003;16: 902-912.
10. Yamaguchi H, Inoue T, Eguchi T, et al Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 2007;20:552-561.
11. Pelosi G, Pastorino U, Pasini F, et al Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer 2003;88:537-547.
12. Hashimoto Y, Ito T, Inoue H, et al Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 2005;11:2597-2605. (Pubitemid 40569459)
13. Hashimoto Y, Shimada Y, Kawamura J, et al The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 2004;67:262-270. (Pubitemid 39551711)
14. Grothey A, Hashizume R, Sahin AA, et al Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer 2000;83:870-873. (Pubitemid 30707621)
15. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002;29:430-438.
16. Hu W, McCrea PD, Deavers M, et al Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000;18:83-88.
17. Hwang JH, Smith CA, Salhia B, et al The role of fascin in the migration and invasiveness of malignant glioma cells. Neoplasia 2008;10:149-159.
18. Yoder BJ, Tso E, Skacel M, et al The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005;11:186-192.
19. Hashimoto Y, Skacel M, Lavery IC, et al Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 2006;6:241.
20. Lee TK, Poon RT, Man K, et al Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 2007;254:308-315.
21. Xie JJ, Xu LY, Zhang HH, et al Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun 2005;337:355-362.
22. Okada K, Shimura T, Asakawa K, et al Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer. Hepatogastroenterology 2007;54:17-21.
23. Swierczynski SL, Maitra A, Abraham SC, et al Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004;35:357-366.
24. Iguchi T, Aishima S, Taketomi A, et al Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Hum Pathol 2009;40:174-180.
25. Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996;23:1341-1344.
26. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545.
27. Federico A, Morgillo F, Tuccillo C, et al Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007;121:2381-2386.
28. Ohira S, Sasaki M, Harada K, et al Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. Am J Pathol 2006;168:1155-1168.
29. Tanimura Y, Kokuryo T, Tsunoda N, et al Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett 2005;219:205-213.
30. Mon NN, Hasegawa H, Thant AA, et al A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res 2006;66:6778-6784.
31. Nakanuma Y, Hoso M, Sanzen T, et al Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply. Microsc Res Tech 1997;38:552-570.
32. Nakanuma Y, Sasaki M, Ikeda H, et al Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. Hepatol Res 2008;38:325-334.
33. Kudo T, Takino T, Miyamori H, et al Substrate choice of membrane-type 1 matrix metalloproteinase is dictated by tissue inhibitor of metalloproteinase-2 levels. Cancer Sci 2007;98:563-568.
34. Jawhari AU, Buda A, Jenkins M, et al Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 2003;162:69-80.
35. Sahai E. Mechanisms of cancer cell invasion. Curr Opin Genet Dev 2005;15:87-96.
36. Itatsu K, Sasaki M, Harada K, et al Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha. Liver Int 2009;29:291-298.
37. Al-Alwan MM, Rowden G, Lee TD, et al Fascin is involved in the antigen presentation activity of mature dendritic cells. J Immunol 2001;166:338-345.
38. Vignjevic D, Schoumacher M, Gavert N, et al Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007;67:6844-6853.
39. Grothey A, Hashizume R, Ji H, et al C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000;19:4864-4875. (Pubitemid 30809023)
40. Zen Y, Adsay NV, Bardadin K, et al Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 2007;20:701-709.
41. Zen Y, Sasaki M, Fujii T, et al Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol 2006;44:350-358.
42. Daponte A, Kostopoulou E, Minas M, et al Prognostic significance of fascin expression in advanced poorly differentiated serous ovarian cancer. Anticancer Res 2008;28:1905-1910.
43. Zhang H, Xu L, Xiao D, et al Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 2006;59:958-964.